Thromboembolic myocardial infarction after transcatheter aortic valve implantation:a spotlight on antithrombotic treatment post-TAVI  

在线阅读下载全文

作  者:Vasileios Kamperidis Anastasios Kartas Georgios Sianos Antonios Ziakas Haralambos Karvounis Stavros Hadjimiltiades 

机构地区:[1]First Cardiology Department,AHEPA University Hospital,Aristotle University of Thessaloniki,Thessaloniki,Greece

出  处:《Journal of Geriatric Cardiology》2021年第4期316-318,共3页老年心脏病学杂志(英文版)

摘  要:The use of dual antiplatelet therapy for the first three–six months after transcatheter aortic valve implantation (TAVI) has been suggested.~([1,2]) However, the additional benefit of anticoagulant therapy during the same period has conflicting data and even the guidelines from different cardiology societies are not in line.

关 键 词:TRANSCATHETER IMPLANTATION therapy 

分 类 号:R542.22[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象